Aim To investigate risk factors for the development of prosthetic joint infection. Methods A group of 50 patients with periprosthetic infection was compared with a group of 100 randomly selected patients with total hip or knee arthroplasty without infectious complications. Twelve risk factors in both groups were analysed. Results Five factors showed to be significant: body mass index higher than 40, diabetes mellitus on insulin therapy, kidney and liver disease, vascular disease of the lower extremities and positive drain tip culture. Conclusion One of the ways to reduce the incidence of periprosthetic infection is the maximum possible elimination of risk factors in patients who have a high probability of endoprosthesis infection. If this elimination is not possible for a long time, it is advisable to consider abandoning the planned operation.
Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatolog Sur Res. 2010;124–32.
2.
Sculco T. The economic impact of infected joint arthroplasty. Orthopedics. 1995;871–3.
3.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Br. 2007;780–5.
4.
Gallo J, Landor I, Vavřík P. Současné možnosti prevence kloubních náhrad. Acta Chir Orthop Traumatol Cech. 2006;229–36.
5.
Phillips J, Crane T, Noy M, Elliott T, Grimer R. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006;943–8.
6.
Pulido L, Ghanem E, Joshi A, Purtill J, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;1710–5.
7.
Namba R, Inacio M, Paxton E. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am. 2013;775–82.
8.
Kunutsor S, Whitehouse M, Blom A. Patientrelated risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;150866.
9.
Berbari E, Hanssen A, Duffy M, Steckelberg J, Ilstrup D, Harmsen W, et al. Risk factors for prosthetic joint infection: Case-control study. Clin Infect Dis. 1998;1247–54.
10.
Jahoda D, Nyc O, Simsa J, Kucera E, Hanek P, Chrz P, et al. Late hematogenous infection of prosthetic joints in our patients and proposal for a system of prevention. Acta Chir Orthop Traumatol Cech. 2007;397–400.
11.
Lenguerrand E, Whitehouse M, Beswick A, Kunutsor S, Burston B, Porter M, et al. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis. 2018;1004–5.
12.
Zhao R, Liang H, Jackson C, Xue C, M. Inflammation in chronic wounds. Int J Mol Sci. 2016;2085.
13.
Berbari E, Osmon D, Lahr B, Eckel-Passow J, Tsaras G, Hanssen A, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol. 2012;774–81.
14.
Mcpherson E, Woodson C, Holtom P, Roidis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;8–15.
15.
Schrama J, Espehaug B, Hallan G, Engesaeter L, Furnes O, Havelin L, et al.
16.
Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res (Hoboken). 2010;473–9.
17.
Momohara S, Kawakami K, Iwamoto T, Yono K, Sakuma Y, Hiroshima R, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;469–75.
18.
Luessenhop C, Higgins L, Brause B, Ranawat C. Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplasty. 1996;862–8.
19.
Hwang J, Kim S, Bamne A. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes? Clin Orthop Relat Res. 2015;1726–31.
20.
Bourne R, Mukhi S, Zhu N, Keresteci M, Marin M. Role of obesity on the risk of total hip and knee arthroplasty. Clin Orthop Relat Res. 2007;185–8.
21.
Dowsey M, Choong P. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res. 2009;1577–81.
22.
Mccleery M, Leach W, Norwood T. Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland. J Bone Joint Surg Br. 2010;1535–9.
23.
Suzuki G, Saito S, Ishii T, Motojima S, Tokuhashi Y, Ryu J. Previous fracture surgery is a major risk factor of infection after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011;2040–4.
24.
Rand J, Fitzgerald R. Diagnosis and management of the infected total knee arthroplasty. Orthop Clin North Am. 1989;201–10.
25.
Poss R, Thornhill T, Ewald F, Thomas W, Batte N, Sledge C. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984;117–26.
26.
Hanssen A, Osmon D. Evaluation of a staging system for infected hip arthroplasty. Clin Orthop Relat Res. 2002;16–22.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
